NEW YORK, March 30, 2016 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Friday, April 1:

• WebMD Health Corp. (NASD: WBMD) will replace SunEdison Inc. (NYSE: SUNE) in the S&P MidCap 400. SunEdison is ranked at the bottom of the index and has a market capitalization that is no longer representative of the mid-cap market space.
• SciClone Pharmaceuticals Inc. (NASD: SCLN) will replace Affymetrix Inc. (NASD: AFFX) in the S&P SmallCap 600. S&P 500 constituent Thermo Fisher Scientific Inc. (NYSE: TMO) is acquiring Affymetrix in a deal expected to be completed soon pending final approvals.

WebMD Health Corp. provides health information services. Headquartered in New York, NY, the company will be added to the S&P MidCap 400 GICS (Global Industry Classification Standard) Internet Software & Services Sub-Industry index.

SciClone Pharmaceuticals provides therapies for oncology, infectious diseases, and cardiovascular disorders. Headquartered in Foster City, CA, the company will be added to the S&P SmallCap 600 GICS Pharmaceuticals Sub-Industry index.

Following is a summary of the changes:

Additions to and deletions from S&P Dow Jones Indices do not in any way reflect an opinion on the investment merits of the companies involved.

For more information about S&P Dow Jones Indices, please visit www.spdji.com

About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is the world's largest, global resource for index-based concepts, data and research. Home to iconic financial market indicators, such as the S&P 500^® and the Dow Jones Industrial Average^®, S&P Dow Jones Indices LLC has over 115 years of experience constructing innovative and transparent solutions that fulfill the needs of investors. More assets are invested in products based upon our indices than any other provider in the world. With over 1,000,000 indices covering a wide range of asset classes across the globe, S&P Dow Jones Indices LLC defines the way investors measure and trade the markets. To learn more about our company, please visit www.spdji.com.

S&P® is a registered trademark of Standard & Poor's Financial Services LLC ("S&P"), a part of McGraw Hill Financial. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"). These trademarks have been licensed to S&P Dow Jones Indices LLC. It is not possible to invest directly in an index. S&P Dow Jones Indices LLC, Dow Jones, S&P and their respective affiliates (collectively "S&P Dow Jones Indices") do not sponsor, endorse, sell, or promote any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. This document does not constitute an offer of services in jurisdictions where S&P Dow Jones Indices does not have the necessary licenses. S&P Dow Jones Indices receives compensation in connection with licensing its indices to third parties.

S&P DJI MEDIA CONTACTS:

David Blitzer
Managing Director and Chairman of Index Committee
New York, USA
(+1) 212 438 3907
[email protected]

Soogyung Jordan
Head of Communications
New York, USA
(+1) 212 438 2297
[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/webmd-health-set-to-join-the-sp-midcap-400-sciclone-pharmaceuticals-to-join-sp-smallcap-600-300243784.html

SOURCE S&P Dow Jones Indices